Pavel V. Belichenko

Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration

Ahmad Salehi, Jean‐Dominique Delcroix, Pavel V. Belichenko et al. · Neuron · 2006 · 547 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome

Alexander M. Kleschevnikov, Pavel V. Belichenko, Angela J. Villar et al. · Journal of Neuroscience · 2004 · 469 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion

Jonathan D. Cooper, Ahmad Salehi, Jean‐Dominique Delcroix et al. · Proceedings of the National Academy of Sciences · 2001 · 338 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome

Pavel V. Belichenko, Eliezer Masliah, Alexander M. Kleschevnikov et al. · The Journal of Comparative Neurology · 2004 · 302 citations

Life Sciences, Neurobiology, Neuroscience +17

Widespread changes in dendritic and axonal morphology in <i>Mecp2</i>‐mutant mouse models of rett syndrome: Evidence for disruption of neuronal networks

Pavel V. Belichenko, Elena E. Wright, Nadia P. Belichenko et al. · The Journal of Comparative Neurology · 2009 · 277 citations

Medicine, Neurobiology, Neuroscience +17